Recombinant Nanobiotechnology for Swallowable Insulin: Innovations in Noninvasive Diabetes Therapy: Recombinant Oral Insulin Nanobiotechnology. Ricos Biology, [S. l.], v. 3, n. 11, p. 15–19, 2025. DOI: 10.33687/ricosbiol.03.011.90. Disponível em: https://ricosbiology.net/journal/article/view/90. Acesso em: 2 apr. 2026.